Craniotomy pain: trying to do better.
Allan
A
Gottschalk
D000284:Administration, Oral; D000588:Amines / Q000008:administration & dosage* / Q000009:adverse effects; D016058:Analgesia, Patient-Controlled; D000700:Analgesics / Q000008:administration & dosage* / Q000009:adverse effects; D000701:Analgesics, Opioid / Q000008:administration & dosage; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects; D003399:Craniotomy / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D000077206:Gabapentin; D006801:Humans; D009020:Morphine / Q000008:administration & dosage; D010147:Pain Measurement; D010149:Postoperative Pain / Q000209:etiology / Q000517:prevention & control*; D010672:Phenytoin / Q000008:administration & dosage; D011229:Preanesthetic Medication; D015173:Supratentorial Neoplasms / Q000601:surgery; D013997:Time Factors; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage* / Q000009:adverse effects
D000588:Amines; D000700:Analgesics; D000701:Analgesics, Opioid; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D010672:Phenytoin; D000077206:Gabapentin; D009020:Morphine